Related Experiment Video
Updated: Jan 6, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
4.1K
Craniopharyngioma - What's next
1Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky Universität Oldenburg, Klinikum Oldenburg AöR, Rahel-Straus-Strasse 10, Oldenburg, 26133, Germany. hermann.mueller@ymail.com.
Pituitary
|November 8, 2025
Summary
Craniopharyngioma treatment can cause hypothalamic obesity, a complex syndrome impacting multiple body systems. New personalized algorithms and medications show promise for managing this challenging condition.
Area of Science:
- Neuroendocrinology
- Oncology
- Metabolic Medicine
Background:
- Craniopharyngioma diagnosis often leads to rapid weight gain and hypothalamic obesity.
- Hypothalamic obesity is part of a broader hypothalamic syndrome with diverse neuroendocrine and physiological impairments.
- This condition significantly increases risks for metabolic syndrome, cardiovascular disease, and reduced quality of life.
